These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23444498)

  • 21. The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults.
    Frenck RW; Yeh S
    Expert Opin Biol Ther; 2012 Jan; 12(1):63-77. PubMed ID: 22074323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indirect effects of childhood pneumococcal vaccination on pneumococcal carriage among adults and older children in Australian Aboriginal communities.
    Mackenzie G; Carapetis J; Leach AJ; Hare K; Morris P
    Vaccine; 2007 Mar; 25(13):2428-33. PubMed ID: 17030493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.
    Quinet B; Laudat F; Gurtman A; Patterson S; Sidhu M; Gruber WC; Scott DA
    Pediatr Infect Dis J; 2014 Oct; 33(10):1065-76. PubMed ID: 25093973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal vaccination in adults: rationale, state of the art and perspectives.
    Icardi G; Sticchi L; Bagnasco A; Iudici R; Durando P
    J Prev Med Hyg; 2012 Jun; 53(2):78-84. PubMed ID: 23240164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
    Giele C; Moore H; Bayley K; Harrison C; Murphy D; Rooney K; Keil AD; Lehmann D
    Vaccine; 2007 Mar; 25(13):2379-84. PubMed ID: 17064825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness.
    Hammitt LL; Bulkow LR; Singleton RJ; Nuorti JP; Hummel KB; Miernyk KM; Zanis C; Whaley M; Romero-Steiner S; Butler JC; Rudolph K; Hennessy TW
    Vaccine; 2011 Mar; 29(12):2287-95. PubMed ID: 21255685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
    de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative safety evaluation of 7-valent and 13-valent pneumococcal vaccines in routine paediatric vaccinations in four Italian regions, 2009 to 2011.
    Trotta F; Rizzo C; Santuccio C; Bella A;
    Euro Surveill; 2015 Feb; 20(7):21-8. PubMed ID: 25719964
    [No Abstract]   [Full Text] [Related]  

  • 32. Pneumococcal immunization in immunocompromised hosts: where do we stand?
    Cordonnier C; Averbuch D; Maury S; Engelhard D
    Expert Rev Vaccines; 2014 Jan; 13(1):59-74. PubMed ID: 24308578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
    Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD;
    Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients.
    Forstner C; Plefka S; Tobudic S; Winkler HM; Burgmann K; Burgmann H
    Vaccine; 2012 Aug; 30(37):5449-52. PubMed ID: 22749594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): a phase 3, open-label trial.
    Silfverdal SA; Flodmark CE; Rombo L; Tansey SP; Sidhu M; Trammel J; Emini EA; Gruber WC; Scott DA; Gurtman A;
    Vaccine; 2013 Feb; 31(9):1284-92. PubMed ID: 23306363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumococcal vaccination in adults: does it really work?
    Pitsiou GG; Kioumis IP
    Respir Med; 2011 Dec; 105(12):1776-83. PubMed ID: 21816596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly.
    van Werkhoven CH; Huijts SM; Bolkenbaas M; Grobbee DE; Bonten MJ
    Clin Infect Dis; 2015 Dec; 61(12):1835-8. PubMed ID: 26265498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan.
    Togashi T; Yamaji M; Thompson A; Giardina PC; Aizawa M; Patterson S; Gruber WC; Scott DA;
    Pediatr Infect Dis J; 2013 Sep; 32(9):984-9. PubMed ID: 23538524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal serotype diversity among adults in various countries, influenced by pediatric pneumococcal vaccination uptake.
    Grabenstein JD; Weber DJ
    Clin Infect Dis; 2014 Mar; 58(6):854-64. PubMed ID: 24344141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.